http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111122872-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_33c168888de52d4532fa19f5af1987a6 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-515 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-325 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
| filingDate | 2019-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_48da0e25337e0a9257d4eb18459b0300 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a7558b9baa25a8b8cddbc5132cdd041 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f757b98c9da279c49c4ab6c313d9f39 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_142a6788028926b07412a35cba54f18e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_def0d0f77c0e1da0016b874ab5cd59f4 |
| publicationDate | 2020-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-111122872-A |
| titleOfInvention | The application of angiopoietin-like protein 7 in the prognosis assessment of heart failure |
| abstract | The invention discloses the application of angiopoietin-like protein 7 in the prognosis assessment of heart failure. When serum samples of patients with heart failure are detected by enzyme-linked immunosorbent assay, when the content of angiopoietin-like protein 7 in the samples is greater than or equal to 869 pg/g When mL is used, the patient has a high probability of poor prognosis, that is, a high probability of 30-day death and 90-day death events. The present invention uses angiopoietin-like protein 7 as a marker for evaluating the prognosis of heart failure, and can determine the prognosis of patients with heart failure by detecting the concentration of ANGPTL7 in serum. The use of this marker to predict the prognosis of patients with heart failure is simple and easy to implement, the results are accurate, and it has a guiding role in clinical treatment plans. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112156091-A |
| priorityDate | 2019-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 279.